A recent analysis highlights the increasing burden of breast cancer globally, predicting a rise in new cases and deaths by 2050 despite advancements in treatment.
A comprehensive analysis published in 'The Lancet Oncology' has revealed alarming projections regarding breast cancer cases worldwide. According to expert Amy Bremner, the report estimates that the number of new breast cancer cases will surge from 2.3 million in 2023 to over 3.5 million by 2050. This stark increase highlights the ongoing challenges in addressing this disease despite improvements in treatment capabilities.
Additionally, the analysis indicates that the mortality rate from breast cancer is expected to nearly double during the same period, increasing from 764,000 deaths to 1.4 million. This disparity underscores the varying impacts of breast cancer across different income levels, with 73% of cases being diagnosed in higher-income countries, while poorer nations bear 39% of breast cancer deaths. The rising mortality rates in low-income countries contrast with the decreasing rates observed in wealthier nations since 1990.
Countries like Belgium and Denmark have reported a consistent annual decrease in breast cancer mortality of about 2.5%, while many African nations have faced rising rates due to socioeconomic factors. This suggests a critical need for targeted interventions and resources to combat breast cancer in poorer nations, addressing both prevention and care issues to mitigate the growing threat of this disease globally.
